Take part in a paid clinical trial

Chronic pancreatitis is a serious disease that causes ongoing inflammation and damage to the pancreas. People living with this condition often experience severe abdominal pain, digestive difficulties, and other long-term health complications. Current treatment options focus mainly on managing symptoms, and there remains a significant need for new therapies that may help slow or prevent disease progression.  

This Phase 1 research study is investigating CBT-248, a novel investigational medicine being developed for chronic pancreatitis. By taking part as a healthy volunteer, you can play an important role in helping researchers understand the safety and pharmacokinetics of this potential future treatment. The knowledge gained from this study may contribute to the future clinical development of CBT-248 for patients affected by chronic pancreatitis. 

Your participation could help shape the future of treatment for this underserved condition. 

This study is looking at a potential new medication for migraine. 

Migraine is a common condition that causes repeated headaches, often with symptoms like sensitivity to light or sound, and can make everyday activities difficult. It affects many people worldwide, especially women, and is one of the leading causes of disability in people under 50. Although treatments are available to relieve symptoms and help prevent migraines, many people still do not get enough relief or may experience side effects. Because of this, there is a need for new treatments that work differently and target the underlying causes of migraine rather than just managing symptoms. 

The study drug is designed to block natural signals in the body that can trigger migraines, which may help prevent them from occurring. 

This clinical study is investigating an investigational vaccine targeting respiratory viruses such as RSV, HMPV and PIV. This investigational vaccine is being developed to address the lack of currently licensed vaccines for prevention of HPMV and PIV. Researchers are evaluating this investigational vaccine to better understand its safety, tolerability and how the body responds to it. 

By conducting this study, researchers hope to gain a better understanding of the medication and how it behaves in different populations, which may help support future clinical development and the design of subsequent research studies to help with protection from respiratory viruses. 

This study is sponsored by a pharmaceutical company.

This clinical study is investigating a potential new medication for weight loss and obesity. The study drug is delivered orally which is easier to take than many other current comparable medications. Researchers believe that this study drug may help with body composition, enhance muscle function and improve glucose and lipid metabolism as it targets different pathways compared to other weight loss medications. 

By conducting this study, researchers hope to gain a better understanding of the medication and how it behaves in different populations, which may help support future clinical development and the design of larger studies to help people with weight loss and obesity.